Anticoagulant rodenticide ingestion: Who will develop coagulopathy?
Open Access
- 8 November 2021
- journal article
- research article
- Published by Wiley in Hong Kong Journal of Emergency Medicine
- Vol. 30 (2), 87-95
- https://doi.org/10.1177/10249079211049939
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Anemia, hypoalbuminemia, and renal impairment as predictors of bleeding complications in patients receiving anticoagulation therapy for nonvalvular atrial fibrillation: A secondary analysisClinical Therapeutics, 2009
- Pharmacokinetics of eight anticoagulant rodenticides in mice after single oral administrationJournal of Veterinary Pharmacology and Therapeutics, 2008
- Assessment of ruminal degradation, oral bioavailability, and toxic effects of anticoagulant rodenticides in sheepAmerican Journal of Veterinary Research, 2006
- The vitamin K cycleJournal of Thrombosis and Haemostasis, 2005
- Paracetamol: a haemorrhagic risk factor in patients on warfarinBritish Journal of Clinical Pharmacology, 2005
- Comparative Pharmacokinetics of Vitamin K AntagonistsClinical Pharmacokinetics, 2005
- Anticoagulant RodenticidesToxicological Reviews, 2005
- Paracetamol (acetaminophen) warfarin interaction: NAPQI, the toxic metabolite of paracetamol, is an inhibitor of enzymes in the vitamin K cycleThrombosis and Haemostasis, 2004
- Acetaminophen Causes an Increased International Normalized Ratio by Reducing Functional Factor VIITherapeutic Drug Monitoring, 2000
- Warfarin and albumin.BMJ, 1982